Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.

about

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists

P2860

Q58581253-BDE76389-C049-48EC-85C9-15974D42DBB0

P2860

Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.

Item

http://www.wikidata.org/entity/Q36946655

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Long lasting MDM2/Translocator ...... s of human glioblastoma cells.

@en

type

Item

label

Long lasting MDM2/Translocator ...... s of human glioblastoma cells.

@en

prefLabel

Long lasting MDM2/Translocator ...... s of human glioblastoma cells.

@en

P1476

Long lasting MDM2/Translocator ...... s of human glioblastoma cells.

@en

P2093

Elisa Zappelli

http://www.w3.org/2001/XMLSchema#string

Elisabetta Barresi

http://www.w3.org/2001/XMLSchema#string

Federico Da Settimo

http://www.w3.org/2001/XMLSchema#string

Luciana Marinelli

http://www.w3.org/2001/XMLSchema#string

Maria L Trincavelli

http://www.w3.org/2001/XMLSchema#string

Sabrina Taliani

http://www.w3.org/2001/XMLSchema#string

Simona Daniele

http://www.w3.org/2001/XMLSchema#string

P2860

AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer

A neoadjuvant, randomized, open-label phase II trial of afatinib versus trastuzumab versus lapatinib in patients with locally advanced HER2-positive breast cancer.

Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

Activation of p53 by nutlin-3a induces apoptosis and cellular senescence in human glioblastoma multiforme

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Malignant gliomas in adults

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Malignant astrocytic glioma: genetics, biology, and paths to treatment

P304

7866-7884

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.6872

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ettore Novellino

Claudia Martini

P577

2016-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290434211

http://www.w3.org/2001/XMLSchema#string

P698

26761214

http://www.w3.org/2001/XMLSchema#string

P932

4884960

http://www.w3.org/2001/XMLSchema#string

Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.

about

P2860

P2860

Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932